China Finds Drug Target for Acute Leukemia
print 
email 
Favorite 
Transtlate Chinese researchers have made new progress in molecular targeted therapy for acute leukemia. According to Shanghai Institute of Hematology in Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and the Research on the Molecular Mechanism to treat Acute Promyelocytic Leukemia (APL) with Arsenic Trioxide conducted by State Key Laboratory of Medical Genomics, oncoprotein PML-RAR is the drug target in the treatment of APL with arsenic.
Up to now, it has been clarified how the different targets in the same oncoprotein are treated in the therapy of “all-transretinoic acid (ATRA) + Arsenic Trioxide” put forward by the research group in Shanghai Institute of Hematology. The research findings will be released in the internationally authoritative journal “Science” today, and Shanghai Institute of Hematology held a press conference in Shanghai this morning.
News&Opinion
more- Chinese Approves Blueprint for National Educatio...
- Shanghai Expo to Stage 20,000 Performances
- Shanghai World Expo News in Brief
- 170,000 volunteers serve the World Expo 2010
- Chinese Language Year Inaugurated in Spain
- Expo Transport System to Be Largest Ever
- Training Program Polishes School Teachers in Wes...
- China's Students Under More Stress Than Other Co...
Policy＆Laws
A new disciplinary policy aiming to curb plagiar...
According to a report by Beijing Daily on January 11, a new discipli...
How to improve Chinese Education?
A total of 48 schools in central and eastern China who aim to upgrad...
Mid-program evaluations give lazy grad students ...
Still working on that thesis five years later? Well, the days of kic...
 |
 |
 |
 |
